Company Directory / research
PrivateFor profitresearchLyon, France
ENYO Pharma
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
- Founded
- 2014 12 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $103M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
12 years old.
Reach
Website ranked #11,784,246 in the world for traffic, about 145 visits a month.
What it does
BiopharmaBiotechnologyMedical
Funding, as listed
$103M currency not stated
- Rounds4
- LatestSeries c, Jan 2024
- Investors11, 5 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about ENYO Pharma, field by field. Contact details are held but never shown.
The company
- Name
- ENYO Pharma
- Type
- For profit
- Status
- Private
- Founded
- 2014
- Founders
- Benoit Chassey, Jacky Vonderscher, Jean-Jacques Garaud, Laurene Schicklin, Patrice Andre, Vincent Lotteau
- Industry
- research
- Categories
- Biopharma, Biotechnology, Medical
Where
- City
- Lyon
- Country
- France
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #11,784,246
- Monthly web visits
- 145
Funding, as listed
- Total
- 103,498,229 (currency not stated)
- Rounds
- 4
- Latest round
- Series c
- Latest round date
- Jan 2024
- Investors
- 11
- Lead investors
- 5
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
ENYO Pharma may be growing as it has successfully secured a significant amount of Series C funding, specifically €39 million, which is indicative of investor confidence and financial backing to advance its clinical programs. This funding is aimed at progressing the development of Vonafexor, a treatment for Alport syndrome, a kidney disease, suggesting an expansion of the company's research and development efforts. The acquisition of this funding also implies that ENYO Pharma is in a position to potentially increase its operational capabilities and invest in furthering its product pipeline.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in France.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 88,142 companies in France and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.